Welcome to medications.com

Toprol-XL Information

What's inside Toprol-XL

Toprol-XL Active Ingredients: metoprolol succinate, details.
Toprol-XL Dosages & Strengths
Strength Format Route Strength Class
Toprol-XL 50 mg tablet, extended release oral 1.0 each OTC
Toprol-XL 200 mg tablet, extended release oral 1.0 each OTC
Toprol-XL 25 mg tablet, extended release oral 1.0 each OTC
Toprol-XL 100 mg tablet, extended release oral 1.0 each OTC

Recent Toprol-XL Side Effects

Posted by kristiparalegal40 5 days ago
I am a 40 year old woman. I was having to do a lot of mediation for my work and discovered I had situational high blood pres...

Posted by tukie14 6 days ago
I have been on Toprol XL for five years now. My heart was beating too fast and after taking multiple test my doctor put me o...

Posted by luckford 6 days ago
I have been on 50 mg. of Toprol xl for 5 years I find it so hard to breathe. Like I have to make myself breathe or I'll just ...


Toprol-XL in the News

ROUNDUP AstraZeneca's strengthened pipeline fails to impress as ... - Euro2day
... chief financial officer Simon Lowth predicted that revenues from MedImmune would cancel out losses incurred from generic competition to Toprol-XL in 2008.
Thu Jan 31 10:57:01 -0500 2008

Intestinal bleeding requires some care immediately - San Bernardino Sun
I was then placed on Toprol XL. After several weeks, I started to get dizzy and lightheaded. I was told to monitor my pressure, which I do. ...
Sat Feb 02 21:01:46 -0500 2008

Intestinal bleeding requires some care immediately - San Gabriel Valley Tribune
I was then placed on Toprol XL. After several weeks, I started to get dizzy and lightheaded. I was told to monitor my pressure, which I do. ...
Sat Feb 02 20:56:50 -0500 2008


Toprol-XL Chemical Information

metoprolol succinate - The succinate salt form of metoprolol, a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol succinate antagonizes beta 1-adrenergic receptors in the myocardium, thereby reducing the rate and force of myocardial contraction, and consequently a diminished cardiac output. This agent may also reduce the secretion of renin with subsequent reduction in levels of angiotensin II thus decreasing sympathetic activation, including vasoconstriction, aldosterone secretion.




ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com